Andy Dzik-Jurasz

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

Dana E. Rathkopf, Bryan Wong, Robert W. Ross et al. · Cancer Chemotherapy and Pharmacology · 2010 · 113 citations

Medicine, Oncology, Pharmacology +11

Human rectal adenocarcinoma: Demonstration of ¹H‐MR spectra in vivo at 1.5 T

Andy Dzik-Jurasz, Philip S. Murphy, Mark George et al. · Magnetic Resonance in Medicine · 2002 · 36 citations

Medicine, Oncology, Radiology +17

Use of biomarkers and imaging to evaluate the treatment effect of AUY922, an HSP90 inhibitor, in patients with HER2+ or ER+ metastatic breast cancer.

C.P. Schröder, J. V. Pedersen, Sue Chua et al. · Journal of Clinical Oncology · 2011 · 25 citations

Medicine, Oncology, Pharmacology +17

A Phase I/II Study of BHQ880, a Novel Osteoblat Activating, Anti-DKK1 Human Monoclonal Antibody, in Relapsed and Refractory Multiple Myeloma (MM) Patients Treated with Zoledronic Acid (Zol) and Anti-Myeloma Therapy (MM Tx).

J. Thaddeus Beck, Kevin R. Kelly, Nikhil C. Munshi et al. · Blood · 2009 · 22 citations

Pharmacy, Hematology, Pharmacotherapy +16